SC 13G

Company

Oruka Therapeutics, Inc.

Filed

June 25, 2015

Accession Number

0001144204-15-039125

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →